1. Home
  2. ELDN vs DC Comparison

ELDN vs DC Comparison

Compare ELDN & DC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELDN
  • DC
  • Stock Information
  • Founded
  • ELDN 2004
  • DC 2017
  • Country
  • ELDN United States
  • DC United States
  • Employees
  • ELDN N/A
  • DC N/A
  • Industry
  • ELDN Biotechnology: Pharmaceutical Preparations
  • DC Precious Metals
  • Sector
  • ELDN Health Care
  • DC Basic Materials
  • Exchange
  • ELDN Nasdaq
  • DC Nasdaq
  • Market Cap
  • ELDN 239.6M
  • DC 212.5M
  • IPO Year
  • ELDN N/A
  • DC N/A
  • Fundamental
  • Price
  • ELDN $4.34
  • DC $2.14
  • Analyst Decision
  • ELDN Strong Buy
  • DC Buy
  • Analyst Count
  • ELDN 1
  • DC 1
  • Target Price
  • ELDN $16.00
  • DC $6.00
  • AVG Volume (30 Days)
  • ELDN 553.2K
  • DC 366.9K
  • Earning Date
  • ELDN 11-12-2024
  • DC 11-13-2024
  • Dividend Yield
  • ELDN N/A
  • DC N/A
  • EPS Growth
  • ELDN N/A
  • DC N/A
  • EPS
  • ELDN N/A
  • DC N/A
  • Revenue
  • ELDN N/A
  • DC N/A
  • Revenue This Year
  • ELDN N/A
  • DC N/A
  • Revenue Next Year
  • ELDN N/A
  • DC N/A
  • P/E Ratio
  • ELDN N/A
  • DC N/A
  • Revenue Growth
  • ELDN N/A
  • DC N/A
  • 52 Week Low
  • ELDN $1.43
  • DC $1.84
  • 52 Week High
  • ELDN $5.54
  • DC $3.25
  • Technical
  • Relative Strength Index (RSI)
  • ELDN 42.46
  • DC 38.48
  • Support Level
  • ELDN $4.32
  • DC $2.20
  • Resistance Level
  • ELDN $4.76
  • DC $2.30
  • Average True Range (ATR)
  • ELDN 0.39
  • DC 0.09
  • MACD
  • ELDN -0.09
  • DC -0.01
  • Stochastic Oscillator
  • ELDN 2.65
  • DC 11.86

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

About DC Dakota Gold Corp.

Dakota Gold Corp is a gold exploration and development company with a specific focus on revitalizing the Homestake District in Lead, South Dakota. Dakota Gold has high-caliber gold mineral properties covering over 48 thousand acres surrounding the historic Homestake Mine.

Share on Social Networks: